This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Willing and able to provide written informed consent and to comply with the requirements of Clinical Investigational Plan
Male or female patients aged 18 years or above
Patients where Matrix and/or Morcells were used as part of their soft tissue reconstruction procedure
Subject that are willing and able to comply with all aspects of the treatment and evaluation schedule
Patients with known sensitivity to ovine (sheep) derived material
Patients with full thickness ('third degree') burns
Patients with wounds with uncontrolled clinical infection (CDC Contamination Grade=4)
Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study